Stoke Therapeutics Presents Data Related to the Ongoing Clinical Development of STK-001 for the Treatment of Dravet Syndrome at the 35th International Epilepsy Congress
DUBLIN--(BUSINESS WIRE)--Sep 5, 2023--
Source: eagletribune.com
Stoke Media News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Stoke Media. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Stoke Media Today - Breaking & Trending Today
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
Press release content from Business Wire. The AP news staff was not involved in its creation. Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates May 10, 2021 GMT BEDFORD, Mass.--(BUSINESS WIRE)--May 10, 2021-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by up-regulating protein expression with RNA-based medicines, today reported financial results for the first quarter of 2021 and provided business updates. “The momentum we are seeing with STK-001 in the clinic is driven...
Source: apnews.com
Stoke Therapeutics Reports Full Year 2020 Financial Results and Provides Business Updates
Press release content from Business Wire. The AP news staff was not involved in its creation. Stoke Therapeutics Reports Full Year 2020 Financial Results and Provides Business Updates March 9, 2021 GMT BEDFORD, Mass.--(BUSINESS WIRE)--Mar 9, 2021-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by up-regulating protein expression with RNA-based medicines, today reported financial results for the full year ended December 31, 2020 and provided business updates. “During the last year, the power and potential of R...
Source: apnews.com